AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $150.14
- 52-wk high
- $176.66
- High
- $155.00
- 52-wk low
- $22.28
- Low
- $128.61
- Prev close
- $133.32
Smart money
Earnings
Earnings landed in line with what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.02B | $678.0M | $389.0M | $145.0M |
| Cost of what it sold | $1.01B | $452.0M | $955.0M | $93.0M |
| Gross profit | $8.0M | $226.0M | -$566.0M | $52.0M |
| What it spent | ||||
| Research and development | $801.0M | $775.0M | $649.0M | $651.0M |
| Sales and admin | $268.0M | $308.0M | $173.0M | $216.0M |
| Other operating costs | -$801.0M | — | — | — |
| Total operating expenses | $268.0M | $1.08B | $822.0M | $867.0M |
| What was left | ||||
| Operating profit | -$260.0M | -$857.0M | -$1.39B | -$815.0M |
| Interest on debt | $0 | $8.0M | $17.0M | $17.0M |
| Profit before tax | -$187.0M | -$799.0M | -$1.33B | -$767.0M |
| Tax | $13.0M | $27.0M | $9.0M | $15.0M |
| Net profit | -$200.0M | -$826.0M | -$1.34B | -$782.0M |
| EBITDA | -$135.0M | -$732.0M | -$1.26B | -$704.0M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
73overbought
20D volatility
382%annualized
52-week range
$22.28$176.66
20D support
News
What the news says
50 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Satellos Bioscience Stock Drops 3.39% as Investors Weigh Duchenne Muscular Dystrophy Therapy, Clinical Development and Biotech Risk
NeutralAug 17FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax
Leans bullishAug 17Attovia Therapeutics debuts with a novel antibody platform targeting chronic itch cytokine IL-31.
Bullish
